Search
03/04/2025
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome
Alcover, S, Ramos-Regalado, L, Girón, G, Muñoz-García, N, Vilahur, G. HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome. Antioxidants. 2025; 14(4)DOI:10.3390/antiox14040434. PMID:40298782. IF:6.600(Q1/1D).
02/04/2025
Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes
Barranco-Altirriba, M, Rossell, J, Alonso, N, Weber, RJM, Ortega, E, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Winder, C, Junza, A, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02701-z. PMID:40176064. IF:10.600(Q1/1D).
01/04/2025
Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial
Marchina, S, Yeatts, SD, Foster, LD, Janis, S, Shoamanesh, A, Khatri, P, Bernstein, K, Perlmutter, A, Stever, C, Heistand, EC, Broderick, JP, Greenberg, SM, Leira, EC, Rosand, J, Lioutas, VA, Salman, RA, Tirschwell, D, Marti-Fabregas, J, Selim, M. Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial. CEREBROVASCULAR DISEASES. 2025; 54(2)DOI:10.1159/000538195. PMID:38493765. IF:1.500(Q3/8D).
01/04/2025
Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease
Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Rusiñol, AB, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martínez, SM, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Rodríguez-Molinero, A. Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease. Clinical Parkinsonism & Related Disorders. 2025; 12DOI:10.1016/j.prdoa.2025.100325. PMID:40329979. IF:(Q/D).
01/04/2025
Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I Study
Arbat, A, Canals, I, Coimbra, J, Molina-Perelló, P, Llorens, M, Torres, R, Perello, J, Moral-Blanch, M, Antonijoan, RM, Calaf, J. Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I Study. International Journal of Fertility & Sterility. 2025; 19(2)DOI:10.22074/ijfs.2024.2013704.1554. PMID:40200776. IF:0.471(Q4/10D).
01/04/2025
Neuropsychological profiles in first-episodes psychosis and their relationship with clinical, metacognition and social cognition variables
Espinosa, V, Bagaeva, A, Lopez-Carrilero, R, Barajas, A, Barrigón, ML, Birulés, I, Frigola-Capell, E, Díaz-Cutraro, L, González-Higueras, F, Grasa, E, Gutiérrez-Zotes, A, Lorente-Rovira, E, Pélaez, T, Pousa, E, Ruiz-Delgado, I, Verdaguer-Rodríguez, M, Ochoa, S. Neuropsychological profiles in first-episodes psychosis and their relationship with clinical, metacognition and social cognition variables. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(3)DOI:10.1007/s00406-024-01813-z. PMID:38806850. IF:3.700(Q1/3D).